Intranasal Delivery of miR133b in a NEO100-Based Formulation Induces a Healing Response in Spinal Cord-Injured Mice.

As shown in Figure 8 A, mice that received miR133b delivered via nasal route showed a decreasing trend, approximately 16%, in Col1a1 expression level when compared to the control treated group ( Figure 8 Ai, t -test, p = 0.23).

also in 47,180 other papers

At 240 min, there was an increasing trend in miR133b level in both miR133b/Ago2 alone and miR133b/Ago2 co-delivered with NEO100 such as: 3.14-fold change vs. 3.07-fold-change, respectively of these groups when compared to the injury only group ( Figure 4 I).

also in 63,971 other papers